InsidersTradesSigma
Track the EQL Pharma AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, EQL Pharma AB has recorded 14 insider filings. Market capitalisation: €756m. The latest transaction was reported on 19 August 2026 (Purchase). Among the most active insiders: Axel Schörling. The full history is accessible without an account.
14
Insider Decl.
n/a
Thresholds
€454,844
9 ops.
Buy Volume
€118,679
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate EQL Pharma AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 47.50.
37Σ signal
Fundamental score
Ranked 22,849 of 29,064 companies
31.7
score / 100
Value30
Quality33
FCF yld-4.9%
Earn yld1.6%
EV/EBITDA18.6x
ROE-1.1%
Gross mgn38%
Net mgn2.9%
Debt/EBITDA6.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
Declarations14 total
20,000 shares@ SEK 26.36AktieISIN SE0005497732FI:csv-f549ec71932406ec2dd2
20,000 shares@ SEK 26.360.068% mcap100.0% of flowAktieISIN SE0005497732FI:csv-bdac4202ec394da54509
24,066 shares@ €4.71440.015% mcap54.7% of flowAktieISIN SE0005497732FI:A003X402-1
1,000 shares@ €5.3350.0007% mcap100.0% of flowAktieISIN SE0005497732FI:A003V099-1
19,225 shares@ €4.81060.012% mcap39.7% of flowAktieISIN SE0005497732FI:A003V027-1
1,000 shares@ €6.14510.0008% mcap100.0% of flowAktieISIN SE0005497732FI:A003S651-1
23,300 shares@ €6.02330.018% mcap60.3% of flowAktieFI:A003S639-1
667 shares@ €7.83030.0007% mcap100.0% of flowAktieISIN SE0005497732FI:A003S329-1
289,155 shares0AktieISIN SE0005497732FI:A003S161-1
38,370 shares0AktieISIN SE0005497732FI:A003S141-2
345,642 shares0AktieISIN SE0005497732FI:A003S140-1
100,000 shares@ €0.66060.0086% mcap31.8% of flowTeckningsoptionFI:A003R671-1
3,650 shares@ €7.65830.0036% mcap13.5% of flowAktieISIN SE0005497732FI:A003O464-1
3,542 shares@ €6.0020.0028% mcap100.0% of flowAktieISIN SE0005497732FI:A003N308-1
14 of 14 declarations
关于 EQL Pharma AB
EQL Pharma AB 是一家专注于仿制药和医药产品开发和商业化的公司。它在斯德哥尔摩证券交易所（XSTO）上市。